Replies to post #1367 on American Cryostem Corp (fka CRYO)

[JJ24]

I would say so .

The Company announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for Phase I, to develop ATCell™, a proprietary expanded autologous adipose-derived mesenchymal stem cell therapy for the treatment of Post-Concussion Syndrome (PCS). PCS is a complex disorder triggered by one or more concussive injuries.

If successful would be a huge win for professional athletes !